About: A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) wüsseschaftlicher Artikel, wo im April 2000 veröffentlicht worden isch (gsw) наукова стаття, опублікована у квітні 2000 (uk) im April 2000 veröffentlichter wissenschaftlicher Artikel (de) article scientifique publié en avril 2000 (fr)
publication date	wds:Q64130818-30B769D8-4448-4CB5-A7DB-5DFBAAEF21AE
publication date	2000-04-28 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q64130818-A583FA5B-7CB8-4FD6-8EEC-82706D83EEFB
language of work or name	English
cites work	wds:Q64130818-0745399C-E977-42EC-B897-B0E97F3B84D7 wds:Q64130818-0CF89922-4E2E-4FD6-AF8A-6FA2C6396B86 wds:Q64130818-0E1A7EE0-C4DD-4BAF-B6CC-82F0A0E29E1E wds:Q64130818-12915E23-FCF3-4ADF-B54D-01003FB5D44C wds:Q64130818-12EC25C3-DE04-4E1B-8FE0-A36B2CEDDF7A wds:Q64130818-14D8F787-A4E1-4C9E-B5E2-FB08FFD52DE2 wds:Q64130818-1A6C4C41-9A25-46E8-930D-2DEC6B323F99 wds:Q64130818-1F818DEF-B454-4C48-927A-7FCFC6A96134 wds:Q64130818-28490FFB-B8A6-4FE1-97AC-00D082C8B9D2 wds:Q64130818-2D70E294-5D57-4326-9425-27FECB475D93 wds:Q64130818-2EE4E93E-808B-4877-B898-48F0EAF52FE9 wds:Q64130818-2F46290E-CEC2-4B1F-A246-2F0BEC990A04 wds:Q64130818-3A06D70D-1478-48D1-A592-1D1E9FCB9EDC wds:Q64130818-3F168D89-0EAC-492D-883D-F3BE88C3A2DE wds:Q64130818-5182EDBE-C536-4822-A8E0-0F47CC371125 wds:Q64130818-52863B47-108A-41CA-9F53-D0DF4EF4C700 wds:Q64130818-573BEEEF-C829-4223-A35B-85639CF45D8C wds:Q64130818-5CE93487-18D1-4382-B4AF-C03FCB56C53B wds:Q64130818-796C862C-8D92-409C-8A7C-D8B426DF1C90 wds:Q64130818-7AA0BD8B-B600-4013-B9F2-918990FC7BAF wds:Q64130818-7E06254D-AD40-460E-9E63-C40F79AF8BFF wds:Q64130818-865EE80E-63F6-4A3F-885F-3B56346954AB wds:Q64130818-868F5FAF-FFF4-4043-B5A9-98C4E346A3F6 wds:Q64130818-8E34C294-5B5B-48CF-8CB1-ECE058122A37 wds:Q64130818-9BF0C320-2D37-4E25-970A-D1907949C0BF wds:Q64130818-AEC20C04-1587-4E38-B24F-37A54772BCB8 wds:Q64130818-B9396F9D-103C-42B7-9F61-5E56CCDD36C8 wds:Q64130818-BDAF42DA-A09E-4DBF-9E63-2EDC1AD84D28 wds:Q64130818-BFEA45C8-967C-4F79-9814-EEF30655D773 wds:Q64130818-CB052C5A-9A18-462F-8A3B-EC6354E87813 wds:Q64130818-CD19F02B-CA1D-4150-9784-4DB4E9CC7679 wds:Q64130818-D247B5EC-66B0-4FD5-8B2B-42A8941F55D7 wds:Q64130818-D85D625B-01C5-4704-A954-41943906002F wds:Q64130818-D99C9D22-EC72-4586-909D-04FB29D7DC98 wds:Q64130818-E174343B-623D-4308-BB6F-55A04A66A7A2 wds:Q64130818-EAECD913-E710-4816-883C-8793F2CAFC7A wds:Q64130818-F35C082A-7F99-4DAB-994A-6DED6D268D88 wds:Q64130818-F3BE1A17-80BB-4D4F-91F7-924CFF42BB2C wds:Q64130818-F78CFA36-F152-4CDC-9AC4-83F4391C1F85
cites work	The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial Pilot evaluation of influenza virus vaccine (IVV) combined with adjuvant Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. Effectiveness of inactivated influenza vaccine among nursing home residents during an influenza type A (H3N2) epidemic Systemic and mucosal immune responses in young children and adults after parenteral influenza vaccination Pandemic versus epidemic influenza mortality: a pattern of changing age distribution Development of adjuvant-active nonionic block copolymers Safety and immunogenicity of a 45-microgram supplemental dose of inactivated split-virus influenza B vaccine in the elderly Antibody response after influenza immunization with various vaccine doses: a double-blind, placebo-controlled, multi-centre, dose-response study in elderly nursing-home residents and young volunteers Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix Diminished influenza A virus-specific MHC class I-restricted cytotoxic T lymphocyte activity among elderly persons Cytotoxic T-cell immunity to influenza. The aging immune system: primer and prospectus Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59. Serious morbidity and mortality associated with influenza epidemics Age-related decline in interleukin 2 production in response to influenza vaccine Calcitriol (1,25-dihydroxy-vitamin D3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers Antibody induction by influenza vaccines in the elderly: a review of the literature Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine Efficacy of influenza vaccine in nursing homes. Reduction in illness and complications during an influenza A (H3N2) epidemic Local reactions of the saponin Quil A and a Quil A containing iscom measles vaccine after intramuscular injection of rats: a comparison with the effect of DPT-polio vaccine Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine Enhancement of the protective efficacy of inactivated influenza A virus vaccine in aged mice by IL-2 liposomes Induction, persistence and strain specificity of haemagglutinin-specific secretory antibodies in lungs of mice after intragastric administration of inactivated influenza virus vaccines Increasing the immunogenicity of a trivalent influenza virus vaccine with adjuvant-active nonionic block copolymers for potential use in the elderly Observations on excess mortality associated with epidemic influenza Enhanced immune responses and resistance against infection in aged mice conferred by Flu-ISCOMs vaccine correlate with up-regulation of costimulatory molecule CD86. Immunization of elderly people with high doses of influenza vaccine Interleukin-2 and aging: decreased interleukin-2 production in healthy older people does not correlate with reduced helper cell numbers or antibody response to influenza vaccine and is not corrected in vitro by thymosin alpha 1. Genetic stability of A/Ann Arbor/6/60 cold-mutant (temperature-sensitive) live influenza virus genes: analysis by oligonucleotide mapping of recombinant vaccine strains before and after replication in volunteers Enhancement of antibody responses to influenza B virus haemagglutinin by use of a new adjuvant formulation The development of effective vaccine adjuvants employing natural regulators of T-cell lymphokine production in vivo Quantitative analysis of the protein composition of influenza A and B viruses using high resolution SDS polyacrylamide gels The Effect of Influenza Vaccination on IL2 Production in Healthy Elderly: Implications for Current Vaccination Practices
author name string	wds:Q64130818-0FDF828D-87F1-489F-9E76-CEAEF284D2B6 wds:Q64130818-249DDC8B-C507-482A-A97E-691A8CDB7705 wds:Q64130818-3C3A1CB4-701D-4855-B768-E5B0F0DA42B2 wds:Q64130818-798453F5-E5E7-45EB-B990-664DCA33D7BF
author name string	X Lu J M Katz C W Todd M J Newman
rdfs:label	A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice (en) A nonionic block co-polymer adjuvant (nl)
skos:prefLabel	A nonionic block co-polymer adjuvant (CRL1005) enhances the immunogenicity and protective efficacy of inactivated influenza vaccine in young and aged mice (en) A nonionic block co-polymer adjuvant (nl)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software